PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12839123::ACT034825

L-CR5

Evidence text

Paper-level observation

In the range of 50–800 μg/mL, the tyrosinase inhibitory rate of L-CR5 gradually increased from 1.16% to 57.35%.
textConfidence: medium

Assay observation

Activity
Antioxidant
Subtype
Tyrosinase Inhibitor
Measure
percent_inhibition
Comparator
~
Raw observation
1.16% (at 50 μg/mL)
Normalized measurement
~1.16%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
mushroom tyrosinase
Assay method
Not reported by source
Sequence
CYGSR
Standardization
ready simple

Source publication

Comparison of In Vitro Multiple Physiological Activities of Cys–Tyr–Gly–Ser–Arg (CYGSR) Linear and Cyclic Peptides and Analysis Based on Molecular Docking

Biomolecules · 2026

DOI 10.3390/biom16010126 PMC12839123
Parent mention

Related peptide identities

PEPDIA-PLP-000379

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.